The Australia Animal Parasiticides Market was valued at $101 Million in 2026 and projected to reach to $133.1 Million by 2031, representing a compound annual growth rate of 5.7%. Australia's animal parasiticides market is poised for steady growth through 2031, driven by the country's strong agricultural foundation and increasing emphasis on animal welfare standards.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia's animal parasiticides market is valued at USD 101.0 million in 2026 and is projected to reach USD 133.1 million by 2031, growing at a CAGR of 5.7%, outpacing global average growth rates.
Australia's extensive pastoral farming operations and growing pet ownership drive significant demand for parasiticide solutions across both livestock and companion animal segments, supporting sustained market expansion.
Australia's robust agricultural industry, including sheep, cattle, and dairy farming, creates consistent demand for effective parasite control products to maintain animal health and productivity.
Stringent Australian veterinary and agricultural regulations ensure high-quality parasiticide products, supporting premium market positioning and consumer confidence in animal health solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | DOGS (Livestock Animal) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.2% from 2026 to 2031 |
| Largest Segment | US (Type) |
| Market Size Base Year (Billions) | ~USD 12.95 (2026) |
| Revenue Forecast (Billions) | ~USD 17.5 (2031) |
| Segments Covered | Type, Animal Type, End User, Livestock Animal, Injectable Type, Product Type |
6 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| AGRIUM INC. | Canada | Private Company | Nitrogen-based crop nutrients,Potash,Phosphate-based crop nutrients, |
| HENRY SCHEIN | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| TEREOS | France | Private Company | Sugar and sweetening ingredients,Starches and plant-based ingredients,Alcohol, ethanol and industrial derivatives, |
| PATTERSON COMPANIES, INC | United States | Private Company | Dental (consumables, equipment, software, services),Animal Health (biologicals, pharmaceuticals, diets, equipment, private label),Corporate and Financing, |
| ZOETIS INC. | United States | Public Company | Companion animal pharmaceuticals (parasiticides, dermatology, pain, anti-infectives),Livestock pharmaceuticals and vaccines,Diagnostics (point-of-care, instruments, reference labs, glucose monitors), |
| MERCK & CO., INC | United States | Public Company | Oncology (Keytruda, Keytruda Qlex, Welireg, ADC collaborations),Vaccines (Gardasil, pediatric, pneumococcal, rotavirus),Animal Health (livestock, Allflex, companion animal), |
| ELANCO | United States | Public Company | Companion animal parasiticides (Seresto, K-9 Advantage, Advantix, Advocate, Credelio family, Interceptor Plus, Drontal family),Companion animal vaccines and therapeutics (Galliprant, Atopica, Milbemax, Onsior, Tru Family and other brands),Cattle products (Rumensin, Baytril, Experior and related), |
| VIRBAC | France | Public Company | Companion-animal parasiticides (Prevexto and related),Companion-animal nutrition & petfood (incl. Vikaly, Ursolyx-linked nutrition),Companion-animal behavior & wellness (Zenidog/Zenifel), |
| CEVA | United States | Public Company | 5G/Cellular Baseband IP (PentaG-RAN, PentaG2, XC20/21/23, Ceva-BX2),Short-Range Connectivity IP (Ceva-Waves Bluetooth/Wi-Fi/UWB/Links/DragonFly),Sensing, Audio, and Motion IP (SensPro, BX1, ClearVox, RealSpace, MotionEngine), |
| VETOQUINOL | France | Public Company | Companion animal chronic-care (mobility, pain, dermatology, behavior, cardio-nephrology),Antiparasitics (internal and external) across species,Livestock antibiotics and udder health, |
| KRKA, D. D., NOVO MESTO | Slovenia | Public Company | Prescription pharmaceuticals – cardiovascular,Prescription pharmaceuticals – CNS and pain,Prescription pharmaceuticals – GI, diabetes, other, |
| ECO - ANIMAL HEALTH LTD. | United Kingdom | Public Company | Aivlosin (macrolide antibiotic),Endectocides and antiparasitics (Ecomectin, Ecoheart, Ecotraz, Ecomintic),Tetracyclines (Chlortetracycline, Oxytetracycline), |
| OUROFINO SAúDE ANIMAL | Brazil | Public Company | Production Animals – Medicines & Vaccines,Production Animals – Additives & Probiotics,Companion Animals – Therapeutics & Preventives, |
Agrium Inc. is a Canadian private company founded in 1992 that employs 15,300 people. The company operates in the agricultural sector, providing products and services to support farming operations.
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a major distributor of healthcare products and services to dental, medical, and veterinary professionals.
Tereos is a French private company founded in 1996 with 10,241 employees. The company operates in the agribusiness and food processing industries.
Patterson Companies, Inc. is a United States private company founded in 1877 with 7,600 employees. The company is a distributor of dental, animal health, and other professional products and services.
Zoetis Inc. is a United States public company founded in 2012 with 14,500 employees. The company is a leading global manufacturer and distributor of medicines and vaccines for animals.
Merck & Co., Inc. is a United States public company founded in 1891 with 74,000 employees. The company is a major pharmaceutical and healthcare company producing medicines, vaccines, and animal health products.
Elanco is a United States public company founded in 1954 with 9,650 employees. The company is a global animal health company that develops and markets medicines and vaccines for livestock and companion animals.
Virbac is a French public company founded in 1968 with 6,442 employees. The company specializes in the development and distribution of veterinary pharmaceuticals and products for animal health.
Ceva is a United States public company founded in 1999 with 400 employees. The company operates in the animal health sector.
Vetoquinol is a French public company founded in 1933 with 2,454 employees. The company develops and manufactures veterinary pharmaceuticals and health products for companion animals and livestock.
Krka, d.d., Novo Mesto is a Slovenian public company founded in 1954 with 13,204 employees. The company is a pharmaceutical manufacturer producing medicines for human and animal health.
Eco-Animal Health Ltd. is a United Kingdom public company founded in 1972 with 200 employees. The company develops and supplies veterinary pharmaceuticals and animal health products.
Ourofino Saúde Animal is a Brazilian public company founded in 1987 with 1,086 employees. The company develops and markets veterinary pharmaceuticals and animal health solutions.
New Zealand's animal parasiticides market is valued at USD 101.0 million in 2026.
New Zealand's animal parasiticides market is projected to reach USD 133.1 million by 2031.
New Zealand's animal parasiticides market is expected to grow at a compound annual growth rate of 5.7% from 2026 to 2031.
Growth in New Zealand's market is driven by strong livestock farming operations, increasing animal health awareness, stringent biosecurity regulations, and demand for sustainable parasite control solutions.
New Zealand's market is dominated by livestock segments including dairy, sheep, and beef farming, alongside a growing companion animal health segment.
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the animal parasiticides market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
In the primary research process, a range of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side included project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the animal parasiticides market. Primary sources from the demand side included R&D and product development teams at animal health companies, veterinary clinicians, procurement managers at veterinary hospitals and clinics, and purchasing heads across livestock farms and animal health distribution networks.

Note: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million. C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the animal parasiticides market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Animal parasiticides or antiparasitics are medications used to prevent, mitigate, and treat internal and external parasitic infestations in companion and livestock animals. Parasiticides are usually categorized as endoparasiticides, ectoparasiticides, and endectocides. They are available in various formulations, such as oral liquids, tablets, injectables, pour-ons, spot-ons, drenches, ear tags, collars, and sprays. A parasiticide is selected depending on the type of parasite, type of animal, and the number of animals to be treated.
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
Full forecast, segment splits, and company analysis for all Animal Parasiticides Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report